Biotin interference: evaluation of an updated thyroglobulin electrochemiluminescent immunoassay

Articles in the same Issue

1. Frontmatter
2. Editorial
3. The clinical value of assessing the inter-method bias: the lesson from prostate specific antigen measurement
4. Mini Review
5. Methods to reduce lipemic interference in clinical chemistry tests: a systematic review and recommendations
6. Opinion Paper
7. Troponin interference with special regard to macrocomplex formation
8. Guidelines and Recommendations from Scientific Societies
9. Use of high-sensitivity cardiac troponins in the emergency department for the early rule-in and rule-out of acute myocardial infarction without persistent ST-segment elevation (NSTEMI) in Italy
10. Genetics and Molecular Diagnostics
11. Effect of preexamination conditions in a centralized-testing model of non-invasive prenatal screening
12. General Clinical Chemistry and Laboratory Medicine
13. Comparative study of human growth hormone measurements: impact on clinical interpretation
14. Establishing pre-analytical requirements and maximizing peptide recovery in the analytical phase for mass spectrometric quantification of amyloid-β peptides 1–42 and 1–40 in CSF
15. Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid
16. Targeted profiling of 24 sulfated and non-sulfated bile acids in urine using two-dimensional isotope dilution UHPLC-MS/MS
17. High-resolution capillary electrophoresis for the determination of carbamylated albumin
18. Real-time monitoring of drug laboratory test interactions: a proof of concept
19. Afamin predicts the prevalence and incidence of nonalcoholic fatty liver disease
20. Reference Values and Biological Variations
21. Blood sampling frequency as a proxy for comorbidity indices when identifying patient samples for review of reference intervals
22. Coagulation parameters in the newborn and infant – the Copenhagen Baby Heart and COMPARE studies
23. Hematology and Coagulation
24. Policies and practices in the field of laboratory hematology in Croatia – a current overview and call for improvement
25. Cardiovascular Diseases
26. Evaluation of the Atellica TnIH cardiac troponin I assay and assessment of biological equivalence
27. Infectious Diseases
28. Inadequate design of mutation detection panels prevents interpretation of variants of concern: results of an external quality assessment for SARS-CoV-2 variant detection
29. Letters to the Editors
30. The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters
31. ACE polymorphism is a determinant for COVID-19 mortality in the post-vaccination era
32. A look at the precision, sensitivity and specificity of SARS-CoV-2 RT-PCR assays through a dedicated external quality assessment round
33. Value of hypocalcemia and thromboinflammatory biomarkers for prediction of COVID-19 severity during the second wave: were all the waves the same?
34. Metagenomic next-generation sequencing (mNGS) confirmed a critical case of severe fever with thrombocytopenia syndrome virus (SFTSV)
35. Biotin interference: evaluation of an updated thyroglobulin electrochemiluminescent immunoassay
36. Evaluation of the Beckman Coulter Access Procalcitonin Assay: analytical and clinical performance
37. Analytical performance evaluation of the new sST2 turbidimetric assay implemented in laboratory automation systems
38. Pre-analytical recommendations and reference values for circulating calprotectin are sample type and assay dependent
39. Congress Abstracts
40. Annual Meeting of the Royal Belgian Society of Laboratory Medicine: “Women’s health: from puberty to menopause”